Harnessing genomics for early cancer detection, risk stratification and prevention.

Abstract excerpt

Therapeutic advances have improved cancer outcomes, but early-stage detection remains the single most important determinant of favorable prognoses across many cancer types. Cancer genomics has yielded detailed maps of somatic mutation and methylation patterns characteristic of different cancers, enabling the development of assays to detect mutation-bearing tumor-derived DNA in tissue biopsies, blood and other...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Mutation
• Share to DNA Methylation
• Share to Early Detection of Cancer